Insights
Search results
Blog | November 09, 2023
Read more
Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book
Read more
Article | March 08, 2023
Read more
This Company's False Compliance With CISPR 11 Resulted in a $12 Million FCA Fine
Read more
Blog | September 15, 2022
What to Know About the USPTO's Duty of Candor Guidance Regarding FDA Submissions
Read more
IP Law Essentials | July 31, 2020
Introduction to Patent Term Extensions (PTE)
Read more
Article | December 19, 2019
The Bad Rap on Pharma: In Defense of Patents
Read more
Webinar | May 31, 2018
Hatch-Waxman 301
Read more
Webinar | January 25, 2018
Hatch-Waxman 201
Read more
Article | May 19, 2017
Uncertainty In Patent Term Extension For Biologics
Read more
Article | January 11, 2017
21st Century Cures Act: No Cure for an FDA Patent Bias
Read more
Blog | December 23, 2016
The First Amendment Does Not Protect All Off-Label Drug Promotion
Read more
Article | June 30, 2016